Institutional Ownership Acrivon Therapeutics, Inc. (ACRV)
This table provides information about the institutional ownership of Acrivon Therapeutics, Inc. (ACRV). We have compiled data on the 59 institutions that hold shares in the stock, with a total of 22.6 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
May 15, 2025 Q1 2025 |
8,340,508
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
5,360,858
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 78.23%
|
|
|
Sands Capital Ventures, LLC
Arlington, VA |
May 14, 2025 Q1 2025 |
2,122,605
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 28.44%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
1,895,519
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 10.57%
|
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
888,130
shares
|
$0
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
767,020
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 3.11%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
674,790
shares
|
$0
0.0% of portfolio
|
Q1 2025
Added 0.47%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
450,391
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 24.66%
|
|
|
Acorn Capital Advisors, LLC
New York, NY |
May 15, 2025 Q1 2025 |
405,237
shares
|
$0
0.57% of portfolio
|
Q4 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
306,111
shares
|
$0
0.0% of portfolio
|
Q1 2025
Added 1.57%
|
|
|
Health Cor Management, L.P.
New York, NY |
Feb 14, 2023 Q4 2022 |
284,201
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
232,551
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 1.71%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
111,320
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 2.21%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
109,025
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 7.07%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2025 Q1 2025 |
77,900
shares
|
$0
0.0% of portfolio
|
Q1 2025
Added 4.42%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
57,519
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 75.79%
|
|
|
Wealthedge Investment Advisors, LLC
New York, NY |
May 13, 2025 Q1 2025 |
56,467
shares
|
$0
0.05% of portfolio
|
Q1 2025
Added 420.1%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
52,100
shares
|
$0
0.0% of portfolio
|
Q1 2025
Added 5.47%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
44,154
shares
|
$0
0.0% of portfolio
|
Q1 2025
Added 19.13%
|
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
35,315
shares
|
$0
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
35,221
shares
|
$0
0.0% of portfolio
|
Q1 2025
Added 1.41%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
32,698
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 14.16%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
27,699
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 10.95%
|
|
|
Baker Bros. Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
22,809
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 56.87%
|
|
|
American Century Companies Inc
Kansas City, MO |
May 13, 2025 Q1 2025 |
17,381
shares
|
$0
0.0% of portfolio
|
Q1 2025
Reduced 1.18%
|